Repare Therapeutics Files 8-K
| Field | Detail |
|---|---|
| Company | Repare Therapeutics Inc. |
| Form Type | 8-K |
| Filed Date | May 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
Repare Therapeutics filed a routine 8-K on May 1st, no major news.
AI Summary
Repare Therapeutics Inc. filed an 8-K on May 1, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing provides no specific financial figures or material events beyond the standard reporting requirements for the period ending May 1, 2025. The company's principal executive offices are located at 7171 Frederick-Banting, Building 2, Suite 270, St-Laurent, Quebec, Canada.
Why It Matters
This 8-K filing indicates standard corporate reporting by Repare Therapeutics Inc. without disclosing specific material events or financial updates that would immediately impact investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for Regulation FD disclosure and exhibits, not indicating any specific new risks or material adverse events.
Key Players & Entities
- Repare Therapeutics Inc. (company) — Registrant
- May 1, 2025 (date) — Date of earliest event reported
- 7171 Frederick-Banting, Building 2, Suite 270 (address) — Principal Executive Offices
- St-Laurent, Quebec, Canada (location) — Principal Executive Offices Location
FAQ
What specific event triggered this 8-K filing?
This 8-K filing is primarily for Regulation FD Disclosure and Financial Statements and Exhibits, indicating standard reporting rather than a specific triggering event.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on May 1, 2025.
What is the primary business of Repare Therapeutics Inc. according to the filing?
The filing lists the Standard Industrial Classification as 'PHARMACEUTICAL PREPARATIONS [2834]'.
Where are Repare Therapeutics Inc.'s principal executive offices located?
The principal executive offices are located at 7171 Frederick-Banting, Building 2, Suite 270, St-Laurent, Quebec, Canada.
Does this filing contain any specific financial results or material business updates?
No, this filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 and does not detail specific financial results or material business updates beyond the reporting categories.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 1, 2025 regarding Repare Therapeutics Inc..